Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Sutro Biopharma (NASDAQ:STRO – Free Report) had its price target trimmed by HC Wainwright from $16.00 to $12.00 in a report published on Tuesday, Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Sutro Biopharma’s Q1 2024 earnings at ($0.95) EPS, Q2 2024 earnings at ($0.97) […]
Sutro Biopharma (NASDAQ:STRO – Free Report) had its price target cut by HC Wainwright from $16.00 to $12.00 in a research note issued to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Sutro Biopharma’s Q1 2024 earnings at ($0.95) EPS, Q2 2024 earnings […]
Genocea Biosciences (NASDAQ:GNCA – Get Free Report) and Sutro Biopharma (NASDAQ:STRO – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Earnings and Valuation This table compares Genocea […]
Sutro Biopharma (NASDAQ:STRO – Get Free Report) and Genocea Biosciences (NASDAQ:GNCA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Profitability This table compares Sutro Biopharma and […]